Raleigh Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
8,403
+388
+5% +$107K 0.59% 52
2026
Q1
$2.37M Buy
8,015
+2,710
+51% +$805K 0.82% 36
2025
Q4
$1.45M Buy
+5,305
New +$1.44M 0.53% 58
2025
Q1
Sell
-52
Closed -$12.1K 661
2024
Q4
$12.1K Buy
52
+9
+21% +$2.07K ﹤0.01% 571
2024
Q3
$9.49K Buy
43
+13
+43% +$2.69K ﹤0.01% 603
2024
Q2
$5.96K Sell
30
-15
-33% -$3.1K ﹤0.01% 652
2024
Q1
$9.69K Buy
45
+27
+150% +$5.67K ﹤0.01% 567
2023
Q4
$3.79K Buy
+18
New +$3.84K ﹤0.01% 789
2022
Q1
Sell
-2
Closed 609
2021
Q4
$0 Buy
+2
New +$440 ﹤0.01% 310

Other funds holding CME

Raleigh Capital Management's CME Position: Q2 2026 in Review

Raleigh Capital Management increased its CME Group (CME) stake by 4.8% in Q2 2026, buying an estimated $107K and bringing the position to 8,403 shares worth $1.86M. The position accounts for 0.59% of the portfolio, ranked #52.

Raleigh Capital Management first reported a position in CME in Q4 2021 and has held it in 9 quarters since. The position peaked at $2.37M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Raleigh Capital Management held 8,403 shares of CME Group worth $1.86M as of Q2 2026.
  • Raleigh Capital Management bought 388 CME Group shares in Q2 2026, an estimated $107K.
  • CME Group made up 0.59% of Raleigh Capital Management's portfolio in Q2 2026, its #52 holding.
  • Raleigh Capital Management first reported a position in CME Group in Q4 2021 and has held it in 9 quarters since.
  • Raleigh Capital Management's CME Group position peaked at $2.37M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.